Brexpiprazole Impurity 25 | CAS 5118-13-8 - Request Quote
Brexpiprazole Impurity 25
| SZ CAT No: | SZ-B011027 |
| CAS No | 5118-13-8 |
| Mol.F. | C8H5BrS |
| Mol.Wt. | 213.1 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Brexpiprazole Impurity 25 is chemically 4-Bromo benzo[b]thiophene. Brexpiprazole Impurity 25 is supplied with detailed characterization data compliant with regulatory guideline. Brexpiprazole Impurity 25 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Brexpiprazole.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 5118-13-8
Purchase 5118-13-8
Order 5118-13-8
Enquire 5118-13-8
price of 5118-13-8
5118-13-8 Supplier
5118-13-8 Manufacturer
5118-13-8 Exporter
buy high quality Brexpiprazole Impurity 25
Purchase Brexpiprazole Impurity 25
Brexpiprazole Impurity 25 suppliers
Brexpiprazole Impurity 25 manufacturers
Brexpiprazole Impurity 25 price
Order Brexpiprazole Impurity 25
Enquire Brexpiprazole Impurity 25
Brexpiprazole Impurity 25 cost
Brexpiprazole Impurity 25 Supplier
Brexpiprazole Impurity 25 Distributor
Brexpiprazole Impurity 25 for Method Validation
Brexpiprazole Reference Standard
Brexpiprazole Impurity 25 for ANDA Filing
Brexpiprazole Impurity 25 for Forced Degradation Studies
Brexpiprazole Impurity 25 Identification Standards
Brexpiprazole Impurity 25 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


